Ensign Group to Detail Growth Strategy at Key Investor Conference

SAN JUAN CAPISTRANO, CA – March 12, 2026 – The Ensign Group, Inc. (Nasdaq: ENSG) is set to provide a detailed look into its corporate strategy next week, as its top executives prepare to take the stage at the influential Oppenheimer 36th Annual Healthcare MedTech & Services Conference. The presentation, scheduled for March 19, is highly anticipated by investors looking for insight into how the skilled nursing and senior living giant plans to continue its aggressive growth trajectory in a rapidly evolving market.

In an announcement today, the company confirmed that a high-level team will represent Ensign. The delegation includes Barry Port, Chief Executive Officer and Chairman of the Board; Suzanne Snapper, Chief Financial Officer; Chad Keetch, Chief Investment Officer; and Adam Willits, President of the company’s significant California-based subsidiaries. Their presentation will cover Ensign's operations, expansion plans, and overall financial health, offering a comprehensive update to the investment community. The event will be webcast live, providing broad access to the company’s latest strategic thinking.

This presentation comes at a pivotal time for the healthcare services industry, which is navigating demographic tailwinds, significant regulatory shifts, and persistent operational challenges. For Ensign, a company that has built its reputation on a disciplined acquisition and operational improvement model, the conference is a key platform to reinforce its value proposition and articulate its vision for the future.

A Proven Playbook for Growth

At the heart of Ensign's story is a relentless and successful growth strategy. The company has become a formidable consolidator in the fragmented skilled nursing and senior living space. In 2025 alone, Ensign added 45 new operations to its portfolio, expanding its footprint into new states like Alabama and Tennessee. This pace of acquisition is not new; as of late 2025, over a third of its skilled nursing operations had been under Ensign's management for less than three years, underscoring the constant influx of new facilities.

This expansion is underpinned by a distinct operational philosophy. Ensign champions a decentralized management model that empowers local leaders to drive clinical excellence and financial performance. The company's investment thesis hinges on acquiring underperforming or well-performing assets and applying this localized leadership approach to improve patient outcomes, which in turn boosts skilled mix revenue, occupancy rates, and profitability. This model has proven effective, allowing the company to successfully integrate a steady stream of new facilities.

Financially, the results of this strategy are robust. The company reported impressive results for fiscal year 2025, with adjusted diluted earnings per share climbing 19.5% to $6.57. GAAP net income saw a 15.4% increase to $344.0 million for the year. This financial strength is further supported by the company's real estate strategy, managed through its captive REIT, Standard Bearer Healthcare REIT, Inc. Standard Bearer provides a strategic vehicle for acquiring and controlling the real estate of its operating facilities, generating significant rental revenue and providing long-term stability. Reflecting this confidence and consistent performance, Ensign raised its dividend for the 23rd consecutive year in December 2025, a signal of its commitment to delivering shareholder value.

Navigating a Complex Healthcare Landscape

While Ensign’s track record is strong, it operates within an industry defined by significant external pressures. The upcoming presentation will be closely watched for clues on how management intends to navigate these challenges. Chief among them is the persistent labor shortage plaguing the entire healthcare sector. With nearly all nursing homes reporting open positions and many struggling to staff at pre-pandemic levels, the pressure is immense. This is compounded by the looming Centers for Medicare & Medicaid Services (CMS) minimum staffing mandate, set to begin its phased implementation in May 2026, which is expected to add further strain on operators.

On the reimbursement front, the picture is mixed. The CMS final rule for fiscal year 2025 provided a net 4.2% increase in Medicare Part A payments for skilled nursing facilities (SNFs), a welcome financial boost. However, this comes with stricter enforcement rules, granting CMS the power to levy more significant financial penalties for health and safety violations. Operators must balance the opportunity of higher rates with the risk of increased regulatory scrutiny.

Despite these hurdles, powerful demographic trends provide a strong tailwind. The aging of the baby boomer generation is fueling historic demand for senior care. Occupancy rates have been on a steady upward climb, with the nursing care occupancy rate reaching 84.5% in the third quarter of 2024, its fourteenth straight quarter of growth. Senior living sectors like assisted and independent living have seen similar gains. For an operator like Ensign, with a vast and growing network of 378 facilities across 17 states, this rising tide of demand represents a substantial long-term opportunity.

The Leadership Steering the Ship

Guiding Ensign through this complex environment is a seasoned leadership team, whose collective experience will be on display at the Oppenheimer conference. CEO and Chairman Barry Port has been with the Ensign family of companies for over two decades, rising from operational roles to the chief executive position. His deep-rooted experience in post-acute care, including service on the board of the American Health Care Association (AHCA), gives him a unique perspective on both strategy and execution.

Chief Financial Officer Suzanne Snapper has been a central figure in the company's financial evolution. Since joining in 2007, she has guided Ensign through its IPO, the strategic spin-offs of CareTrust REIT and The Pennant Group, and the formation of the Standard Bearer REIT. Her steady financial stewardship has been critical to funding the company's ambitious growth. Her recent appointment to The Pennant Group's Board of Directors and as President of Insignia Pathways, an initiative supporting the future nursing workforce, further underscores her influence across the industry.

The team is rounded out by Chief Investment Officer Chad Keetch, a key voice in the company's acquisition and capital strategy, and Adam Willits, whose role as president of the California subsidiaries highlights the importance of regional leadership in executing Ensign's ground-level playbook. The presence of this diverse leadership team at the conference signals a unified message that connects high-level investment strategy with proven operational excellence. Investors will be listening intently as they articulate the next chapter of Ensign's growth story.